The product information for Gardasil® has been updated to include the clinical efficacy and safety of the vaccine for women up to 45 years of age. - The product information of the four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® has been updated to include the … [Read more...] about MERCK Press Release Touting Clinical Efficacy of Gardasil for Mature Women
Merck
Cervarix On Track for FDA Approval, Garasil to Have Expanded Use
FDA experts back Merck's application to extend the use of Gardasil to males In twin votes likely to add considerable force to U.S. marketing efforts for HPV vaccines, an FDA expert panel has voted to back GlaxoSmithKline's long delayed application to market its HPV vaccine … [Read more...] about Cervarix On Track for FDA Approval, Garasil to Have Expanded Use
Is Merck Overselling a Cancer Vaccine?
Fresh controversies are heating up over the marketing of products to prevent cervical cancer The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck … [Read more...] about Is Merck Overselling a Cancer Vaccine?
Gardasil is proven dangerous, yet it is still mandatory for immigrants
This week has shown that a large number of reports stating that Gardasil is proving unsafe. News stations around the world have reported that Gardasil the HPV vaccine has been found to cause adverse reactions. The adverse reactions range from mild, such as headaches, nausea and … [Read more...] about Gardasil is proven dangerous, yet it is still mandatory for immigrants
FDA, CDC Continues Their Support of HPV Vaccine Gardasil
Merck clings to FDA, CDC endorsement in light of JAMA article In the wake of new safety data on Merck's human papillomavirus vaccine, both FDA and the Centers for Disease Control and Prevention have issued a statement supporting the product. "Based on the review of available … [Read more...] about FDA, CDC Continues Their Support of HPV Vaccine Gardasil